UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
CNS drugs, ISSN 1172-7047, 2010, Volume 24, Issue 2, pp. 131 - 161
Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Humans | Psychotherapy | Psychotropic Drugs - administration & dosage | Treatment Outcome | Clinical Trials as Topic | Vagus Nerve Stimulation | Transcranial Magnetic Stimulation | Depression - drug therapy | Deep Brain Stimulation | Antidepressive Agents - administration & dosage | Electroconvulsive Therapy | Depression - therapy | Drug Therapy, Combination | Drug Resistance
Journal Article
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 05/2013, Volume 70, Issue 7, pp. 1 - 9
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Humans | Male | Attention Deficit Disorder with Hyperactivity - drug therapy | Substance-Related Disorders - complications | Central Nervous System Stimulants - therapeutic use | Central Nervous System Stimulants - adverse effects | Substance-Related Disorders - epidemiology | Adolescent | Attention Deficit Disorder with Hyperactivity - complications | Adult | Female | Odds Ratio | Child | Longitudinal Studies | Index Medicus | Abridged Index Medicus
Journal Article
Psychological bulletin, ISSN 0033-2909, 9/2011, Volume 137, Issue 5, pp. 717 - 741
Stimulant | Amphetamine | Enhancement | Psychopharmacology | Neuroethics | Psychology, Multidisciplinary | Psychology | Social Sciences | Cognitive Processes | Stimulants | College Students | Drug Therapy | Cognitive Ability | Evidence | Epidemiology | Short Term Memory | Scientific Research | Incidence | Drug Use | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | United States - epidemiology | Neurosciences | Learning - drug effects | Humans | Memory, Short-Term - drug effects | Cognition - drug effects | Students - psychology | Amphetamines - therapeutic use | Central Nervous System Stimulants - therapeutic use | Prescription Drugs - therapeutic use | Methylphenidate - therapeutic use | Intelligence - drug effects | Off-Label Use - statistics & numerical data | Executive Function - drug effects | Cognition | Research | Prescription drugs | Cognitive psychology | Index Medicus | neuroethics | amphetamine | psychopharmacology | stimulant | enhancement
Journal Article
Expert review of neurotherapeutics, ISSN 1473-7175, 02/2016, Volume 16, Issue 2, pp. 131 - 144
Antidepressants | Attention Deficit Hyperactivity Disorder (ADHD) | Amphetamines | Efficacy | Lithium | Adults | Pharmacological Treatment | Metadoxine | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | Paroxetine - therapeutic use | Venlafaxine Hydrochloride - therapeutic use | Dopamine Agents - therapeutic use | Droxidopa - therapeutic use | Pyrrolidonecarboxylic Acid - therapeutic use | Adrenergic alpha-Agonists - therapeutic use | Histamine Agents - therapeutic use | Central Nervous System Stimulants - therapeutic use | Desipramine - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Pyridoxine - therapeutic use | Adult | Lobeline - therapeutic use | Benzhydryl Compounds - therapeutic use | Nomifensine - therapeutic use | Morpholines - therapeutic use | Bupropion - therapeutic use | Pyridines - therapeutic use | Wakefulness-Promoting Agents - therapeutic use | Duloxetine Hydrochloride - therapeutic use | Guanfacine - therapeutic use | Nicotinic Agonists - therapeutic use | Attention Deficit Disorder with Hyperactivity - drug therapy | Antidepressive Agents - therapeutic use | Mecamylamine - therapeutic use | Amphetamines - therapeutic use | Lithium Compounds - therapeutic use | Lisdexamfetamine Dimesylate - therapeutic use | Nicotinic Antagonists - therapeutic use | Quinazolinones - therapeutic use | Memantine - therapeutic use | Drug Combinations | Index Medicus
Journal Article
European neuropsychopharmacology, ISSN 0924-977X, 10/2017, Volume 27, Issue 10, pp. 1064 - 1076
Pharmacoepidemiology | Adult | Antipsychotic agents | Aged | Internationality | Minors | NATIONAL TRENDS | SAFETY WARNINGS | DISEASE PATTERNS | PREVALENCE | BIPOLAR DISORDER | CHILDREN | DRUG USE | ADOLESCENTS | ANTIDEPRESSANT USE | MENTAL-HEALTH-CARE | Neurosciences | Clinical Neurology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Neurosciences & Neurology | Psychiatry | Science & Technology | Prevalence | Age Factors | Cross-Sectional Studies | Humans | Middle Aged | Drug Therapy - utilization | Child, Preschool | Infant | Young Adult | Antipsychotic Agents - therapeutic use | Adolescent | Sex Factors | Child | Infant, Newborn | Drug Therapy - trends | Index Medicus | Medicin och hälsovetenskap
Journal Article
6.
Full Text
Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target
The American journal of psychiatry, ISSN 0002-953X, 1/2013, Volume 170, Issue 1, pp. 23 - 30
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Desintoxication. Drug withdrawal | Medical sciences | Neuropharmacology | Treatments | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Naltrexone - therapeutic use | Substance-Related Disorders - rehabilitation | Mood Disorders - psychology | Antipsychotic Agents - adverse effects | Humans | Sertraline - adverse effects | Alcoholism - diagnosis | Bipolar Disorder - diagnosis | Depressive Disorder, Major - epidemiology | Psychotropic Drugs - therapeutic use | Mood Disorders - epidemiology | Psychotropic Drugs - adverse effects | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Mood Disorders - rehabilitation | Sertraline - therapeutic use | Drug Therapy, Combination | Alcoholism - psychology | Antimanic Agents - adverse effects | Substance-Related Disorders - diagnosis | Bipolar Disorder - rehabilitation | Antimanic Agents - therapeutic use | Double-Blind Method | Comorbidity | Narcotic Antagonists - adverse effects | Depressive Disorder, Major - rehabilitation | Combined Modality Therapy | Controlled Clinical Trials as Topic | Alcoholism - epidemiology | Alcoholism - rehabilitation | Bipolar Disorder - psychology | Antidepressive Agents - therapeutic use | Depressive Disorder, Major - psychology | Narcotic Antagonists - therapeutic use | Mood Disorders - diagnosis | Substance-Related Disorders - psychology | Cognitive Therapy | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Naltrexone - adverse effects | Bipolar Disorder - epidemiology | Diagnosis, Dual (Psychiatry) | Psychological aspects | Drug abuse | Care and treatment | Physiological aspects | Mood (Psychology) | Psychotherapy | Health aspects | Methods | Bipolar disorder | Mental depression | Index Medicus | Abridged Index Medicus
Journal Article